or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    HCM B Hutchison China MediTech Limited 0.10
    LBPH B Longboard Pharmaceuticals, Inc. -1.56
    HALO C Halozyme Therapeutics, Inc. 1.94
    LGND C Ligand Pharmaceuticals Incorporated 9.75
    BIIB C Biogen Idec Inc. 0.37
    SUPN D Supernus Pharmaceuticals, Inc. 0.48
    INCY D Incyte Corporation -1.58
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    PJP A PowerShares Dynamic Pharmaceuticals 11.18
    FBT D First Trust Amex Biotech Index Fund 10.33
    IBRN D iShares Neuroscience and Healthcare ETF 9.08
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.05
    PBE C PowerShares Dynamic Biotech & Genome 7.93
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare BIS to PBE Compare IBRN to BIS Compare PJP to PBE

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        May 8 HALO Q1 2024 Halozyme Therapeutics Inc Earnings Call
        May 8 BIIB Q1 2024 Abcellera Biologics Inc Earnings Call
        May 8 HALO Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
        May 8 LGND Ligand Pharmaceuticals Inc (LGND) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
        May 8 LGND Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
        May 8 LGND Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript
        May 8 LGND Q1 2024 Agenus Inc Earnings Call
        May 7 HALO Halozyme Therapeutics, Inc. (HALO) Q1 2024 Earnings Call Transcript
        May 7 LGND Ligand Pharmaceuticals Inc (LGND) Reports Mixed Q1 2024 Results: Misses Revenue Estimates but ...
        May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
        May 7 HALO Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
        May 7 LGND Agenus (AGEN) Q1 2024 Earnings Call Transcript
        May 7 LGND Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
        May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
        May 7 SUPN Supernus Pharmaceuticals Q1 2024 Earnings Preview
        May 7 HALO Halozyme Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 7 LGND Ligand Pharmaceuticals Non-GAAP EPS of $1.20 beats by $0.37, revenue of $30.98M beats by $3.06M
        May 7 LGND Ligand Pharmaceuticals Incorporated 2024 Q1 - Results - Earnings Call Presentation
        May 7 HALO Halozyme Therapeutics Non-GAAP EPS of $0.79 beats by $0.09, revenue of $195.88M misses by $3.77M
        May 7 HALO HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags